SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

Piper Jaffray Maintains Overweight on Aerie Pharmaceuticals, Lowers Price Target to $48

Piper Jaffray maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Overweight and lowers the price target from $53 to $48.

Benzinga · -

Piper Jaffray maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Overweight and lowers the price target from $53 to $48.